A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC (Q63578506)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC |
clinical trial |
Statements
MAGELLAN (English)
0 references
A Phase IB, Open-Label, Multi-Center Study to Determine the Efficacy and Safety of Durvalumab in Combination With Novel Oncology Therapies, With or Without Chemotherapy, for First-Line Stage IV Non Small Cell Lung Cancer (NSCLC) (MAGELLAN) (English)
0 references
27 December 2018
0 references
25 December 2020
0 references
200
0 references
18 year
0 references
130 year
0 references